| | | | | Oil prices edged higher on Monday, rebounding further from 1-1/2-year lows reached in December, on support from OPEC production cuts and steadying equities markets. | | |
| | | The head of Canada's auto union said on Monday he was set to meet with General Motors Co executives in Detroit on Tuesday to discuss the automaker's Oshawa, Ontario, assembly plant, scheduled to shut down in December 2019. | | |
| | | Morgan Stanley, Fidelity Investments, Citadel Securities LLC and a host of other financial companies plan to launch a low-cost bourse that will compete with the New York Stock Exchange and Nasdaq. | | |
| | | An index of world stocks rose on Monday, adding to Friday's strong gains, on optimism about the outcome of trade talks between Washington and Beijing. | | |
| | | Eli Lilly and Co said on Monday it will buy Loxo Oncology Inc for $8 billion, an expensive bet on a pipeline of cancer drugs that target rare genetic mutations and the biggest acquisition in Lilly's 143-year history. The price represents a 68 percent premium to Loxo's Friday share price close, which some analysts said was high for a company with one approved drug that it shares with a partner. | | |
| | | Asian-controlled leasing companies splashed out on passenger jets worth $25 billion at list prices to pick out bargains as planemakers Airbus and Boeing raced to end a relatively quiet year with fresh orders. | | |
| | | SoftBank Corp is in talks to invest $2 billion in U.S. shared office space provider WeWork Cos Inc this year, a much lower amount than the $16 billion discussed towards the end of last year, the Financial Times reported on Monday. | | |
| | | Amazon.com Inc and Microsoft Corp fueled a second straight session of gains on Wall Street on Monday, with the resumption of U.S.-China trade talks helping ease concerns that have pummeled the market in recent months. | | |
| | | Amgen Inc on Monday lost its bid at the U.S. Supreme Court to overturn a ruling that kept the Regeneron Pharmaceuticals Inc and Sanofi SA cholesterol-lowering drug Praluent on the market, but the patent dispute among the rival drugmakers will continue in another trial. | | |
| | | Activist hedge fund Starboard Value LP on Monday called on Dollar Tree Inc to sell its underperforming Family Dollar business and proposed replacing a majority of the board after revealing a stake in the U.S. discount retailer. | | |
|
| |
